01.14.26 -- LSC Editors' Roundtable: Wrapping Up 2025 And Looking Ahead

Producing high-quality oligonucleotides demands precise execution across multiple stages. Gain a clearer understanding of the complete mid-scale production workflow and necessary QC measures.

Discover the latest innovations in monoclonal antibody purification and explore resin selection strategies to optimize product quality and improve process efficiency.

Biological components in conditioned media are a consistent problem during downstream processing of EVs. A novel in-process reagent prevents these issues and improves particle recovery 10-fold while maintaining CQAs.

Explore the critical role of PUPSIT in quality risk management, as well as learn about integrity testing, wetting procedures, and innovative filtration systems for effective implementation.

Rapidly purify 24 monoclonal antibody samples in under eight hours with a membrane-based affinity capture that streamlines cell line optimization and accelerates early-stage bioprocess development.

Optimize purification steps and determine with confidence whether process steps and parameters are effective before investing resources in regulatory supporting validation studies using live virus.

Annex 1’s updated CCS framework calls for a holistic contamination strategy. Examine how manufacturers can apply it to non-sterile sites and legacy facilities using tailored risk-based approaches.

See how adopting a harmonized, risk-based validation strategy across global sites can reduce operational readiness timelines and drive improvements in equipment effectiveness and compliance.

Single-use technology and innovative fluid connections play a significant role in creating an effective, sterile fill and finish operation that maintains the integrity of your biologic products.